After a terrible 2019, pot stocks are positioned for a massive turn around this year and County Line Energy Corp. (OTC: CYLC) could experience one of the biggest bounces of them all!
There’s no denying that 2019 wasn’t the best year for marijuana-related stocks. In fact, pot stocks had a very sour year. From its March peak, the marijuana-focused ETFMG Alternative Harvest ETF (MJ) lost half its value before the year even ended.
But what a start to 2020 for cannabis on Wall Street… There has been a monstrous rebound already with marijuana-related ETF’s soaring!
In just one week in January the Horizons Marijuana Life Sciences Index ETF saw an increase of 19.11%, the ETFMG Alternative Harvest ETF gained 13.87%, and the Cannabis ETF advanced 16.9%.
“Cannabis stocks seem to be slowly inching their way out of the bear market they’ve been in,” commented Debra Borchardt, CEO of Green Market Report. She added, “We’re seeing companies make adjustments to cultivation plans, restructuring debt and merge for strength as markets open more slowly than planned. Improvements in valuations are sure to ease the concerns of many investors.”
From an oversupply of marijuana and little progress towards federal level legalization, 2019 was a bust for the arena. 2020 however could be shaping up to become a tremendous year for cannabis stock gains.
The industry is politically driven and this is an election year. It also helps that nearly all of the Democratic runners for president are all pro-marijuana and want the plant legal in the U.S. A pot-friendly president could majorly shake up the industry and in a good way!
Shares of County Line Energy Corp. (OTC: CYLC) could be next to start bouncing back as they were as high as almost 46 cents in October before retracing. This is a company that could be hitting on all cylinders this year and the upside potential from here could be a beast!
With an estimated 1/3rd of America’s marijuana being grown inside according to motherjones.com., this is what could turn County Line Energy Corp. (OTC: CYLC) into one of the most opportunistic plays on Wall Street!
County Line Energy Corp. (OTC: CYLC) through its wholly-owned operating subsidiary D5 Partners, Inc., is the developer and distributor of the Grow Box 5000 family of self-contained, fully automated, and expandable smart hydroponics systems for use in growing plants and vegetables.
The company’s mission is to customize ecosystems that enable people to grow their own vegetables, hemp, and cannabis in the most advanced way possible.
The GROW BOX 5K is fully automated and can be controlled from your smartphone which means you can set it up and walk away. Multiple Grow Boxes can also be linked together and controlled from a single interface.
Product highlights include: Easy to use, saves users money, fully automated, and has the best technology and construction.
According to GreenCoastHydroponics.com, the GROW BOX 5k “is the most advanced Grow System” they have ever seen!
One in 3 households is now growing food — this the highest overall participation and spending levels that have been seen in a decade according to the company.
Millennials represent a big chunk of this segment, moving from 8 million growers in 2008 to 13 million in 2013.
The world is going “green” and not just with vegetables, but with cannabis. County Line Energy Corp. (OTC: CYLC)’s Grow Box 5k systems may be the go-to destination for anyone looking to grow their own cannabis at home.
State cannabis laws vary, with some states permitting home growing of marijuana while others do not. Hemp can also be grown legally for personal reasons/recreation in states where cannabis has been legalized recreationally.
The 2018 National Gardening Survey found 15% of US households would grow marijuana at home if it was legal. This number could grow a lot higher as marijuana’s promised benefits continue to be learned by many.
If marijuana were to become legal on a federal level, everyone may be able to start growing discreetly at home. Prohibition looks like it may be on its last legs.
Support for legalizing the plant has also reached an all-time high in America according to the latest Gallup poll.
A survey from Yahoo News and Marist College has illustrated just how mainstream marijuana has become with early 55 million adults currently using the plant.
GROW BOX 5K was created with a focus on creating a platform that promotes indoor Cannabis production on all scales.
It’s hard to believe that today the idea of growing marijuana is as acceptable as it is. There was a time when people had to cultivate the drug in secrecy but now several states allow users to grow their own plants at home. We may soon see every state allowing this if marijuana is legalized across the U.S.
Eric Dena, D5 Partners, Inc. CEO and Grow Box 5000 co-creator, has said:
“Grow Box 5000 represents the cumulative expertise of over 30 years of building highly complicated machines and products for consumers across the globe. The Grow Box 5000 series incorporates decades of professional growing know-how into an attractive, yet powerful design, that’s fully automated and easy to use, from the comfort of your own home, and completely controlled from your computer or smartphone.”
Dena has also stated:
“We are confident that many potential growers, particularly in the rapidly expanding regulated and legalized cannabis and medical marijuana space, will embrace this technology to automate and simplify their personal-scale operations.”
The GB5K units can be custom skinned to integrate with any type of home décor. They are also going to be available in a variety of sized to ensure households of any size will have the most efficient outcome.
County Line Energy Corp. (OTC: CYLC) also allows users to control their growing right from their smartphones!
It was only this past December that the company announced that the Grow Box 5000 (“GB5K”) Alpha Series is now available for sale!
The GB5K self-enclosed ecosystem simplifies the growing process for medicinal plants, fresh vegetables, and growing processes for growing a variety of plants in a controlled or uncontrolled environment.
The Semi-Autonomous Series Alpha units are available immediately and will be fully upgradeable as the Company develops the autonomous Phase 2 units, scheduled for delivery in Q1 2020.
The GB5K Series Alpha units can be custom skinned to integrate with any type of home décor. It is ideally suited to grow up the following varieties: basil, chives, mint, oregano, watercress, kale, lettuce, rosemary, dill, parsley, okra, small carrots, peppers, Thai chili, jalapenos, bell and other peppers, cherry tomatoes, and of course, cannabis.
“We’ve had quite a few inquiries for the purchase of our product since we announced our test results in September. So for those people who don’t want to wait, we are offering the Alpha units for sale through our website,” stated Emanuel Margaretis, co-inventor of the Grow Box 5000.
The company also recently gave the green light to the phase 2 development of the Grow Box 5000.
With Phase 1 complete, County Line Energy Corp. (OTC: CYLC) has decided to move to Phase 2, which includes fully automated systems for advanced growing and management prototypes.
The global legal marijuana market size is expected to reach USD 66.3 billion by the end of 2025, according to a new report by Grand View Research, Inc.!
The image of cannabis has changed. No longer is it just an illegal substance with a negative stigma.
There are hundreds of chemical compounds in cannabis, many of which are cannabinoids. Cannabinoids have been linked to providing relief of chronic pain due to their chemical makeup.
This is why cannabis’ by-product such as medical cannabis is commonly used for chronic pain relief.
You will be surprised to know just how many studies have been done on the plant and what it is said to be capable of.
A study published in the journal Molecular Cancer Therapeutics found that cannabidiol has the ability to stop cancer by turning off a gene called Id-1.  In 2007, researchers at California Pacific Medical Center in San Francisco, reported that CBD may prevent cancer from spreading. The researchers experimented on breast cancer cells in the lab that had a high level of Id-1 and treated them with cannabidiol.
The cells had decreased Id-1 expression and were less aggressive spreaders.
The American Association for Cancer Research has also found that marijuana actually works to slow down tumor growth in the brain, breast, and lungs considerately.
Insomnia, anxiety, depression, seizures, inflammation, PTSD… these are just some of the other conditions that cannabis is said to help alleviate or treat.
When one analyst predicts that legal marijuana could soon become a bigger industry than soda, it says something.
One of the top marijuana analysts, Vivien Azer at Cowen, is calling for total U.S. cannabis sales to hit $80 billion by 2030!
Although competitors exist in the market such as Leaf, Grobo, Trim, leaf, Home Grow Rooms/Tents, Aero Garden, and Miracle-Gro, County Line Energy Corp. (OTC: CYLC) has competitive advantage over them on the basis of broader experience in global manufacturing with a very strong background in bringing commercial products to consumers.
Moreover, the company does not need to rely on subcontractors and vendors to construct and design the products and most of the skills required are in-house.
Hemp is also said to have enormous environmental, economic, and commercial potential and growers could be looking at County Line Energy Corp. (OTC: CYLC) for their needs. The 2018 Farm Bill legalized the regulated production of hemp.
It was only last October that County Line Energy Corp. (OTC: CYLC) launched public pre-orders for its flagship Grow Box 5000 self-contained smart hydroponics systems.
The company is still very much in the early stages of its endeavors and at these levels, the stock could be a true ground-floor situation! County Line Energy Corp. (OTC: CYLC) just began sales of its Grow Box 5k and this could be the beginning of an incredible future for the company!
DISCLAIMER – THIS NEWSLETTER IS A PAID ADVERTISEMENT, NOT A RECOMMENDATION NOR AN OFFER TO BUY OR SELL SECURITIES. THIS NEWSLETTER IS OWNED, OPERATED AND EDITED BY ARCHANGEL MEDIA CONSULTING, LLC. ANY WORDING FOUND IN THIS E-MAIL OR DISCLAIMER REFERENCING TO “I” OR “WE” OR “OUR” OR “ARCHANGEL MEDIA” REFERS TO ARCHANGEL MEDIA CONSULTING, LLC. OUR BUSINESS MODEL IS TO BE FINANCIALLY COMPENSATED TO MARKET AND PROMOTE SMALL PUBLIC COMPANIES. BY READING OUR NEWSLETTER AND OUR WEBSITE YOU AGREE TO THE TERMS OF OUR DISCLAIMER, WHICH ARE SUBJECT TO CHANGE AT ANY TIME. WE ARE NOT REGISTERED OR LICENSED IN ANY JURISDICTION WHATSOEVER TO PROVIDE INVESTMENT ADVICE OR ANYTHING OF AN ADVISORY OR CONSULTANCY NATURE AND ARE THEREFORE ARE UNQUALIFIED TO GIVE INVESTMENT RECOMMENDATIONS. ALWAYS DO YOUR OWN RESEARCH AND CONSULT WITH A LICENSED INVESTMENT PROFESSIONAL BEFORE INVESTING. THIS COMMUNICATION IS NEVER TO BE USED AS THE BASIS OF MAKING INVESTMENT DECISIONS AND IS FOR ENTERTAINMENT PURPOSES ONLY. AT MOST, THIS COMMUNICATION SHOULD SERVE ONLY AS A STARTING POINT TO DO YOUR OWN RESEARCH AND CONSULT WITH A LICENSED PROFESSIONAL REGARDING THE COMPANIES PROFILED AND DISCUSSED. CONDUCT YOUR OWN RESEARCH. COMPANIES WITH A LOW PRICE PER SHARE ARE SPECULATIVE AND CARRY A HIGH DEGREE OF RISK, SO ONLY INVEST WHAT YOU CAN AFFORD TO LOSE. BY USING OUR SERVICE YOU AGREE NOT TO HOLD OUR SITE, ITS EDITOR’S, OWNERS, OR STAFF LIABLE FOR ANY DAMAGES, FINANCIAL OR OTHERWISE, THAT MAY OCCUR DUE TO ANY ACTION YOU MAY TAKE BASED ON THE INFORMATION CONTAINED WITHIN OUR NEWSLETTERS OR ON OUR WEBSITE.
WE DO NOT ADVISE ANY READER TO TAKE ANY SPECIFIC ACTION. LOSSES CAN BE LARGER THAN EXPECTED IF THE COMPANY EXPERIENCES ANY PROBLEMS WITH LIQUIDITY OR WIDE SPREADS. OUR WEBSITE AND NEWSLETTER ARE FOR ENTERTAINMENT PURPOSES ONLY. NEVER INVEST PURELY BASED ON OUR ALERTS. GAINS MENTIONED IN OUR NEWSLETTER AND ON OUR WEBSITE MAY BE BASED ON END-OF-DAY OR INTRADAY DATA. THIS PUBLICATION AND THEIR OWNERS AND AFFILIATES MAY HOLD POSITIONS IN THE SECURITIES MENTIONED IN OUR ALERTS, WHICH WE MAY SELL AT ANY TIME WITHOUT NOTICE TO OUR SUBSCRIBERS, WHICH MAY HAVE A NEGATIVE IMPACT ON SHARE PRICES. ARCHANGEL MEDIA’S BUSINESS MODEL IS TO RECEIVE FINANCIAL COMPENSATION TO PROMOTE PUBLIC COMPANIES. WE HAVE BEEN COMPENSATED A FEE OF FORTY THOUSAND US DOLLARS VIA BANK WIRE FOR A ONE-WEEK CYLC AWARENESS CAMPAIGN BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. PREVIOUSLY, WE WERE COMPENSATED A FEE OF SEVENTY-FIVE THOUSAND US DOLLARS VIA BANK WIRE FOR A ONE-MONTH CYLC AWARENESS CAMPAIGN BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. PREVIOUSLY, WE WERE COMPENSATED TWO HUNDRED THOUSAND DOLLARS BY A THIRD PARTY, BLUE DIAMOND EQUITIES, LLC. THIS COMPENSATION IS A MAJOR CONFLICT OF INTEREST IN OUR ABILITY TO BE UNBIASED REGARDING. THEREFORE, THIS COMMUNICATION SHOULD BE VIEWED AS A COMMERCIAL ADVERTISEMENT ONLY. WE HAVE NOT INVESTIGATED THE BACKGROUND OF THE HIRING THIRD PARTY OR PARTIES. ANY NON-COMPENSATED ALERTS ARE PURELY FOR THE PURPOSE OF EXPANDING OUR DATABASE FOR THE BENEFIT OF OUR FUTURE FINANCIALLY COMPENSATED INVESTOR RELATIONS EFFORTS. FREQUENTLY COMPANIES PROFILED IN OUR ALERTS MAY EXPERIENCE A LARGE INCREASE IN VOLUME AND SHARE PRICE DURING THE COURSE OF INVESTOR RELATIONS MARKETING, WHICH MAY END AS SOON AS THE INVESTOR RELATIONS MARKETING CEASES. THE INVESTOR RELATIONS MARKETING MAY BE AS BRIEF AS ONE DAY, AFTER WHICH A LARGE DECREASE IN VOLUME AND SHARE PRICE IS LIKELY TO OCCUR. OUR EMAILS MAY CONTAIN FORWARD-LOOKING STATEMENTS, WHICH ARE NOT GUARANTEED TO MATERIALIZE DUE TO A VARIETY OF FACTORS.
WE DO NOT GUARANTEE THE TIMELINESS, ACCURACY, OR COMPLETENESS OF THE INFORMATION ON OUR SITE OR IN OUR NEWSLETTERS. THE INFORMATION IN OUR EMAIL NEWSLETTERS AND ON OUR WEBSITE IS BELIEVED TO BE ACCURATE AND CORRECT, BUT HAS NOT BEEN INDEPENDENTLY VERIFIED AND IS NOT GUARANTEED TO BE CORRECT. THE INFORMATION IS COLLECTED FROM PUBLIC SOURCES, SUCH AS THE PROFILED COMPANY’S WEBSITE AND PRESS RELEASES, BUT IS NOT RESEARCHED OR VERIFIED IN ANY WAY WHATSOEVER TO ENSURE THE PUBLICLY AVAILABLE INFORMATION IS CORRECT. FURTHERMORE, ARCHANGEL MEDIA OFTEN EMPLOYS INDEPENDENT CONTRACTOR WRITERS WHO MAY MAKE ERRORS WHEN RESEARCHING INFORMATION AND PREPARING THESE COMMUNICATIONS REGARDING PROFILED COMPANIES. INDEPENDENT WRITERS’ WORKS ARE DOUBLE-CHECKED AND VERIFIED BEFORE PUBLICATION, BUT IT IS CERTAINLY POSSIBLE FOR ERRORS OR OMISSIONS TO TAKE PLACE DURING EDITING OF INDEPENDENT CONTRACTOR WRITER’S COMMUNICATIONS REGARDING THE PROFILED COMPANY(S). YOU SHOULD ASSUME ALL THE INFORMATION IN ALL OF OUR COMMUNICATIONS IS INCORRECT UNTIL YOU PERSONALLY VERIFY THE INFORMATION, AND AGAIN ARE ENCOURAGED TO NEVER INVEST BASED ON THE INFORMATION CONTAINED IN OUR WRITTEN COMMUNICATIONS. THE INFORMATION IN OUR DISCLAIMERS IS SUBJECT TO CHANGE AT ANY TIME WITHOUT NOTICE.
Is CytoDyn Inc. (OTCMKTS:CYDY) A Buy?
CytoDyn Inc (OTCMKTS:CYDY) has been making big moves lately, which have propelled the stock from December low of $0.270 to new highs. Notably, CytoDyn’s surge has come on significant volume as well, a clear sign of strong investor interest in the stock.
The excitement in CytoDyn stock that we are witnessing right now comes as the company has taken a leading role in the fight against the deadly Wuhan coronavirus. Moreover, investors have started pouring on CytoDyn stock as the company advances the development of its lead drug candidate as a treatment for about two dozen different cancer types.
Before we delve into the details, here is a brief profile of CytoDyn for those investors who may have just come across this company for the very first time.
CytoDyn operates in the healthcare sector as a biotechnology company. It is engaged in developing innovative treatments for a broad range of medical indications. Its lead product candidate is leronlimab (PRO 140). Clinical trials of leronlimab are ongoing for conditions such as HIV and multiple cancers with impressive results already attained. But CytoDyn is expanding its target conditions with leronlimab in the wake of the outbreak of the Wuhan coronavirus.
Here are some of the recent developments at CytoDyn that have excited renewed investor interest in its stock.
CytoDyn’s leronlimab under consideration as Wuhan potential coronavirus treatment
CytoDyn’s lead drug candidate leronlimab (PRO 140)…
Rainmaker Worldwide Inc (OTCMKTS:RAKR) Looking For Bagholders
On the OTC Markets, there are a lot of pump and dumps. Investors need to protect themselves from these types of scams and one, in particular, is Rainmaker Worldwide Inc (OTCMKTS:RAKR).
OTCMKTS:RAKR Price Action
While the price action recently has been positive, it’s just a matter of time before RAKR is trading in the double zeros again. It’s not a question of if it will happen, but when it will happen.
About Rainmaker Worldwide
According to its profile, Rainmaker Worldwide Inc. is headquartered in Peterborough, Canada, with an innovation and manufacturing center in Rotterdam, Netherlands. Its patented water technology provides economical drinking water wherever it’s needed and at scale. Rainmaker builds two types of energy-efficient, fresh water-producing technologies to participate in this opportunity. 1. Air-to-Water, which harvests fresh water from humidity in the atmosphere. 2. Water-to-Water, which transforms seawater or polluted water into drinking water.
Lack of Fundamentals
The biggest concern facing investors is the lack of fundamentals. OTCMKTS:RAKR has a current market cap of $41 milli0n, but reported just $1000 in sales in the quarter ending September 30, 2019. Making matters worse is that Rainmaker burned through $524,000 in the quarter. Throughout its history, Rainmaker has lost $14.7 million.
EU Horizon 2020 Project and $2.5 million grant
Last September, Rainmaker touted the award of the European Union (EU) Horizon 2020 Project for Rainmaker’s Water to Water Product. According to the press…
Why Lexaria Bioscience Corp (OTCMKTS:LXRP) Is A Comeback Play
Lexaria Bioscience Corp (OTCMKTS:LXRP) brightest days lie ahead. The sentiments shared by Chief Executive Officer, Chris Bunka, are slowly coming to fruition, going by recent price action activity. After a steep pullback in 2019, the stock has once again started climbing higher, as investors react to milestones achieved in 2019 that affirm long-term prospects.
Lexaria Bioscience Catalysts and Price Analysis
A confirmation that the global innovator in drug delivery systems achieved almost everything it set out to accomplish in 2019 continues to strengthen market sentiments. The inking of strategic partnerships with Fortune 500 style companies is another development that the management continues to tout.
Likewise, Lexaria Bioscience succeeded in getting its DehydraTECH technology to market, consequently creating an avenue for generating long-term value. The company’s Intellectual Property strategy has also started to pay dividends, affirming what is at stake going forward. Reports that the company is already experiencing an increase in revenues is another catalyst that continues to shore the stock’s sentiments and prospects in the markets.
Lexaria Bioscience has already started bottoming out from all-time lows in what appears to be the development of a positive trend. A 10% plus rally from one-year lows continue to fuel optimism that the stock has clocked a bottom and due for a correction higher.
Standing in the way of the emerging uptrend is the $0.50 mark, which is the immediate short-term resistance level. A rally followed by a close above the…